An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

Clinical trial NCT00250250 · COMPLETED

Trial details

NCT number: NCT00250250
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Turner's Syndrome

Start date: 2005-10-01
Primary completion: 2006-03-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.